Do pharmaceutical budgets deliver financial sustainability in healthcare? Evidence from Europe

•Pharmaceutical budgets are frequently used as a means of cost-containment.•GDP-linked budgets neither address drivers of expenditure or promote efficiency.•Silo budgeting reduces flexibility in allocating health resources optimally.•Soft budgets lack enforcement and are frequently overrun.•Complimentary policy measures are needed to promote health system objectives.